Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening Products

Mapping HIV's March Around Europe
Those travelling abroad should take seriously advice to pack their condoms and keep their needles to themselves: research published today in the open access journal Retrovirology shows that tourists, travellers and migrants from Greece, Portugal, Serbia and Spain actively export HIV-1 subtype B to other European nations.
generic viagra online
Kennedy's CLASS Act Would Establish National Long Term Care Insurance
Congress is starting to tackle long-term care through a measure for a national long-term insurance program, according to the New York Times The New Old Age blog.
News of the day
Mental Health America Honors Outstanding Advocates At Its Centennial Conference
-Mental Health America honored two extraordinary mental health advocates on Saturday during the final day of its Centennial Conference.
Medical Devices

Teva Announces Approval And Launch Of Tri-Lo Sprintec Tablets

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company"s Abbreviated New Drug Application (ANDA) to market a generic version of Ortho McNeil Janssen"s oral contraceptive, Ortho Tri-Cyclen® Lo. Shipment of this product, for which Teva"s trade name is Tri-Lo Sprintec, has commenced. As the first company to file an ANDA containing a paragraph IV certification for this product, Teva has been awarded a 180-day period of marketing exclusivity. Annual sales of Ortho Tri-Cyclen® Lo were approximately $400 million in the United States for the twelve months that ended March 31, 2009 based on IMS sales data. Teva is currently involved in patent litigation concerning this product in the U.S. District Court for the District of New Jersey. A trial date has not been set. Teva Pharmaceutical Industries Ltd.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009